This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Salmonella carrier (S. typhi & S. paratyphi)

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

All patients with typhoid and paratyphoid excrete the organisms at some stage during their illness

  • about 10% of patients with typhoid excrete S. typhi for at least three months following the acute illness and 2–5% become long-term carriers (more than one year). The likelihood of becoming a chronic carrier increases with age, especially in females and those with biliary tract abnormality.

Chronic urinary carriage tends to only occur in the presence of urinary tract abnormalities, and in countries where schistosomiasis is endemic, this may be significant.

The V1 antibody is present in approximately 70% of carriers (at 1:5 dilution). This antibody occurs in only about 1% of the UK population.

Reference:

  1. Immunisation Against Infectious Disease - "The Green Book".Chapter 33 Typhoid (August 2006).
  2. Mandal, BH (1992), Salmonella Infections, Medicine International, 105, 4393-4397.

Create an account to add page annotations

Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.